SCHEMBL18396162

SCHEMBL18396162

CCCCCNc1nc(N)c2cc(-c3c(Cl)cccc3Cl)c(=O)[nH]c2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 12/20 0.46
▸ SRC P12931 6/20 0.46
▸ EGFR P00533 6/20 0.45
▸ ABL1 P00519 1/20 0.40
▸ TLR7 Q9NYK1 4/20 0.39
▸ KDR P35968 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ CDK9 P50750 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16986327 0.84 FGFR1 (0.46) FGFR1SRCEGFRABL1TLR7
SCHEMBL16287646 0.78 NPC1 (0.45) FGFR1SRCEGFRABL1KDM4E
SCHEMBL16986359 0.78 DHFR (0.41) FGFR1SRCEGFRKDRFGFR2
SCHEMBL16986308 0.68 FGFR1 (0.39) FGFR1SRCEGFRFGFR2FGFR4
SCHEMBL4739652 0.65 APP (0.45) KDM4EMEN1NPC1ALDH1A1LMNA
SCHEMBL16986338 0.65 NPC1 (0.46) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL16986344 0.65 ADRB2 (0.48) KDM4EMEN1NPC1ALDH1A1MAPT
SCHEMBL16986341 0.64 FGFR1 (0.57) FGFR1SRCEGFRABL1FGFR2
SCHEMBL16986333 0.64 TLR8 (0.41) TLR7MAPTHTT
SCHEMBL23260499 0.63 NPY5R (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3120851-A1 4-AMINO-6-(2,6-DICHLOROPHENYL)-8-METHYL-2-(PHENYLAMINO)-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE FOR TREATMENT OF SOLID CANCERS Pangaea Biotech S.L. (ES) 2017-01-25 — — EP disclosed
Send feedback